Comparison of the efficacy of free and non-ionic-surfactant vesicular formulations of paromomycin in a murine model of visceral leishmaniasis

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 12, 1998, Pages 1351-1356

  Williams, D ^a,b   Mullen A B ^a   Baillie, A J ^a   Carter, K C ^a,c  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Moorfield Industrial Estate   (United Kingdom)

^c Todd Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; PAROMOMYCIN; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; LEISHMANIA DONOVANI; LIVER; MOUSE; NONHUMAN; SPLEEN; VISCERAL LEISHMANIASIS;

EID: 0345435167     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb03358.x     Document Type: Article

References (15)

1. Ankarcrona, M., Dypbukt, J. M., Brune, B., Nicotera, P. (1994) Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cell. Exp. Cell Res. 213: 172-177
2. Baillie, A. J., Coombs, G. H., Dolan, T. F., Hunter, C. A., Laakso, T., Sjöholms, I., Stjärnkvist, P. (1987) Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. J. Pharm. Pharmacol. 39: 832-835
3. Berman, J. D. (1997) Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24: 684-703
4. Bradley, D. J., Kirkley, J. (1977) Regulation of Leishmania populations within the host. I The variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol. 30: 119-129
5. Carter, K. C., Baillie, A. J., Alexander, J., Dolan, T. F. (1988) The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. J. Pharm. Pharmacol. 40: 370-373
6. Grit, M., Underberg, W. J. M., Crommelin, D. J. A. (1993a) Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J. Pharm. Sci. 82: 262-366
7. Grit, M., Zuidam, N. J., Underberg, W. J. M., Crommelin, D. J. A. (1993b) Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics. J. Pharm. Pharmacol. 45: 490-495
8. Jha, T. K., Olliaro, P., Thakur, C. P., Kanyok, T. P., Singhania, B. L., Singh, I. J., Singh, N. K., Akhoury, S., Jha, S. (1998) Randomized controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India. Br. Med. J. 316: 1200-1205
9. Konings, A. W. T. (1984). Lipid peroxidation in liposomes. In: Gregoriadis, G. (ed.) Liposome Technology. 1st edn, Boca Raton, CRC Press, pp 139-161
10. Mullen, A. B., Carter, K. C., Baillie, A. J. (1997) A comparison of the efficacy of various formulations of amphotericin B against murine visceral leishmaniasis. Antimicrob. Agents Chemother. 41: 2089-2092
11. Palmer, R. M. J., Ferrige, A. G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxant factor. Nature 327: 524-526
12. Thakur, C, P., Olliaro, P., Gothoskar, S., Bhowmick, S., Choudhury, B. K., Prasad, S., Kumar, M., Verma, B. B. (1992) Treatment of visceral leishmaniasis (kala-azar) with aminosidine (paromomycin)-antimonial combinations, a pilot study in Bihar, India. Trans. R. Soc. Trop. Med. Hyg. 86: 615-616
13. Tollemar, J., Ringden, O. (1995) Formulations of Amphotericin B. Drug Safety 13: 207-218
14. Umansky, V., Bucur, M., Schirrmacher, V., Rocha, M. (1997) Activated endothelial cells induce apoptosis in lymphoma cells: role of nitric oxide. Int. J. Oncol. 10: 465-471
15. Williams, D. M., Carter, K. C., Baillie, A. J. (1995) Visceral leishmaniasis in the BALB/c mouse: a comparison of the in vivo activity of five non-ionic surfactant vesicle preparations of sodium stibogluconate. J. Drug Targeting 3: 1-7